Please assess the completion status of the following clinical trial:

Trial Title: Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients before elective Heart valve - or aortocoronary by pass surgery with heart-lung-machine.~Exclusion Criteria:~* Pregnant patients~* Patients with preoperative atrial fibrillation and/or hyperthyreosis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Placebo globules group (Type: PLACEBO_COMPARATOR): Patients receive Placebo globules made out of sugar and looking similar to active drug sublingually before surgery.
- Nux vomica group (Type: ACTIVE_COMPARATOR): Patients receive Nux vomica globules made out of sugar sublingually before surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).